BridgeBio Pharma, Inc. (BBIO) › EPS (Diluted)BridgeBio Pharma, Inc. (BBIO) — EPS (Diluted)Annual figures by period end, from SEC filings.2020-12-31: $-3.802021-12-31: $-3.902022-12-31: $-3.262023-12-31: $-3.952024-12-31: $-2.882025-12-31: $-3.78$-3.782020-12-31EPS (Diluted) (USD/shares)2025-12-31Period endedEPS (Diluted)Change YoYSource filing2025-12-31$-3.78—2026-02-24From 2025-01-012024-12-31$-2.88—2026-02-24From 2024-01-012023-12-31$-3.95—2026-02-24From 2023-01-012022-12-31$-3.26—2025-02-20From 2022-01-012021-12-31$-3.90—2024-02-22From 2021-01-012020-12-31$-3.80—2023-02-23From 2020-01-01Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeTotal AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per ShareWeighted Average Diluted SharesEPS (Basic)